Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors.
about
Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent.Respiratory syncytial virus limits alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha) phosphorylation to maintain translation and viral replicationProliferative expansion and acquisition of effector activity by memory CD4+ T cells in the lungs following pulmonary virus infectionVirus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infectionProtection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion proteinPriming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challengeSecreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism.Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challengeVaccinia virus vectors: new strategies for producing recombinant vaccines.Respiratory syncytial virus F envelope protein associates with lipid rafts without a requirement for other virus proteins.Distinct types of lung disease caused by functional subsets of antiviral T cells.Protection of macaques against infection with simian type D retrovirus (SRV-1) by immunization with recombinant vaccinia virus expressing the envelope glycoproteins of either SRV-1 or Mason-Pfizer monkey virus (SRV-3).Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteinsNucleotide sequence analysis and expression from recombinant vectors demonstrate that the attachment protein G of bovine respiratory syncytial virus is distinct from that of human respiratory syncytial virus.Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.Synthesis, cellular location, and immunogenicity of bovine herpesvirus 1 glycoproteins gI and gIII expressed by recombinant vaccinia virusStructure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation.Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated miceHigh-frequency homologous recombination in vaccinia virus DNA.Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice.Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.Vaccinia virus expression vectors.The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons.Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus.
P2860
Q30304128-CD8889B8-10E0-4050-89F3-A5870F3D5BD2Q30431312-0B7A9F94-13F4-46A1-98C2-D3C7945600ADQ30436432-C087870C-D883-4222-B7EA-3F5C3151CBB8Q30442832-3652AA52-3440-4FBB-A7E9-5CDBB2C80723Q30452584-7321513C-CE2E-49C5-B8A4-D8CD6A96E1E5Q33554501-B7DAFA96-D63D-4840-80E3-E5303573DA96Q33783066-3D869AAC-CFDE-4F68-8675-A3C790F352AFQ33820420-A4264A36-FFD4-4EC3-B90D-E342E84FEA4BQ33928414-D0B6A595-42E0-4EBD-8485-406772F29C3FQ34211635-6AA69D56-601A-4A08-AAC9-86AEF249B7F4Q35185963-22CF9FF9-AB4C-437E-9F88-6A371CE961B4Q36362647-E304D1EC-3BB3-46CF-B315-7C4AE0932094Q36698561-015E5F5C-6D03-4FD2-BCDC-4DF00C60C2A4Q36780922-03F8F343-0747-4368-B4EF-06E25E53B15FQ36793445-E6DFE215-F0B8-46E5-8DB0-F675D33606D5Q36802770-41C1DC1D-562B-43C1-82B3-380C335D61B8Q36827447-C694EAA9-EB2A-4374-B4E8-B356697D3EE6Q36831654-E7800E83-16B9-4B5B-8231-16DBE1F97C6FQ36884312-CABDAA03-E17D-444A-B09D-F0F57F4DD529Q36888529-F7AA230D-71F8-4EB1-A4D9-3FD8F87A10D7Q36918751-D2D44EA7-25DA-480E-B65C-04B61FEE732CQ36919232-6F7EC5C9-3C0B-463F-93BF-EC1A14C1C39FQ36920250-4B1E751D-B23B-4F0D-9EDF-D2F0FF1FFC76Q37401975-2E1631DB-3A4D-4AF6-AE2E-A0DB3F25C11DQ38776417-56A632FA-7A5A-49CF-BD6A-D59E19C089E3Q40038247-C2A2CE71-96A9-4F0D-9441-3DC2E93390C2Q40127535-DE6ED275-6F5E-479E-AC6E-8A629E7B54D6Q40308643-98424785-CD3C-4AB4-831E-EE710114531BQ40579448-7671942F-EB1B-401B-AE58-2627FD0DF221
P2860
Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Expression of the major glycop ...... binant vaccinia virus vectors.
@ast
Expression of the major glycop ...... binant vaccinia virus vectors.
@en
type
label
Expression of the major glycop ...... binant vaccinia virus vectors.
@ast
Expression of the major glycop ...... binant vaccinia virus vectors.
@en
prefLabel
Expression of the major glycop ...... binant vaccinia virus vectors.
@ast
Expression of the major glycop ...... binant vaccinia virus vectors.
@en
P2093
P2860
P356
P1476
Expression of the major glycop ...... binant vaccinia virus vectors.
@en
P2093
P2860
P304
P356
10.1073/PNAS.83.2.246
P407
P577
1986-01-01T00:00:00Z